Literature DB >> 26003186

Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice.

Giridhar Kanuri1, Marianne Landmann1, Josephine Priebs1, Astrid Spruss2, Marina Löscher2, Doreen Ziegenhardt1, Carolin Röhl2, Christian Degen1, Ina Bergheim3.   

Abstract

PURPOSE: Using ob/ob mice as a model of non-alcoholic fatty liver disease (NAFLD), we investigated the effect of moderate alcohol intake on the development of NAFLD and molecular mechanisms involved.
METHODS: Ob/ob mice were fed water or ethanol solution (2.5 g/kg body weight/day) for 6 weeks, and markers of liver injury, insulin signalling and adiponectin in visceral adipose tissue were determined.
RESULTS: Whereas bodyweight and the degree of liver steatosis did not differ among ob/ob mouse groups, those consuming ethanol had markedly less macrovesicular hepatic fat accumulation, inflammatory alterations and significantly lower transaminase levels. Despite similarly elevated protein levels of tumour necrosis factor α, protein concentrations of plasminogen activator inhibitor 1 were significantly lower in livers of ob/ob mice consuming ethanol in comparison with controls. The hepato-protective property of moderate alcohol ingestion in ob/ob mice was associated with an induction of the sirtuin-1/adiponectin-signalling cascade in visceral fat tissue and an activation of Akt in the liver. Similar effects of moderate alcohol exposure were also found in vitro in 3T3-L1 and AML-12 cells.
CONCLUSION: These data suggest that moderate alcohol intake may diminish the development of NAFLD through sirtuin-1/-adiponectin-dependent signalling cascades.

Entities:  

Keywords:  Adiponectin; Ethanol; PAI-1; SIRT1; Visceral fat

Mesh:

Substances:

Year:  2015        PMID: 26003186     DOI: 10.1007/s00394-015-0929-7

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  55 in total

1.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.

Authors:  E Araki; M A Lipes; M E Patti; J C Brüning; B Haag; R S Johnson; C R Kahn
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

Review 2.  Wine, beer and spirits and the risk of myocardial infarction: a systematic review.

Authors:  T J Cleophas
Journal:  Biomed Pharmacother       Date:  1999-10       Impact factor: 6.529

3.  Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK.

Authors:  Jun Xu; Keane K Y Lai; Alla Verlinsky; Aurelia Lugea; Samuel W French; Marcus P Cooper; Cheng Ji; Hidekazu Tsukamoto
Journal:  J Hepatol       Date:  2011-01-21       Impact factor: 25.083

4.  Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).

Authors:  Winston Dunn; Arun J Sanyal; Elizabeth M Brunt; Aynur Unalp-Arida; Michael Donohue; Arthur J McCullough; Jeffrey B Schwimmer
Journal:  J Hepatol       Date:  2012-04-17       Impact factor: 25.083

Review 5.  Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

Authors:  György Baffy
Journal:  J Hepatol       Date:  2009-03-31       Impact factor: 25.083

6.  Aggravation of nonalcoholic steatohepatitis by moderate alcohol consumption is associated with decreased SIRT1 activity in rats.

Authors:  André F Nascimento; Blanche C Ip; Renata A M Luvizotto; Helmut K Seitz; Xiang-Dong Wang
Journal:  Hepatobiliary Surg Nutr       Date:  2013-10       Impact factor: 7.293

7.  Alcohol consumption and mortality: modelling risks for men and women at different ages.

Authors:  Ian R White; Dan R Altmann; Kiran Nanchahal
Journal:  BMJ       Date:  2002-07-27

Review 8.  Molecular mechanisms of alcoholic fatty liver.

Authors:  Vishnudutt Purohit; Bin Gao; Byoung-Joon Song
Journal:  Alcohol Clin Exp Res       Date:  2008-11-19       Impact factor: 3.455

9.  Cinnamon extract protects against acute alcohol-induced liver steatosis in mice.

Authors:  Giridhar Kanuri; Synia Weber; Valentina Volynets; Astrid Spruss; Stephan C Bischoff; Ina Bergheim
Journal:  J Nutr       Date:  2009-01-06       Impact factor: 4.798

10.  High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase.

Authors:  Masayuki Adachi; David A Brenner
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

View more
  9 in total

1.  Combinatorial Preconditioning of Rat Brain Cultures with Subprotective Ethanol and Resveratrol Concentrations Promotes Synergistic Neuroprotection.

Authors:  N Khodaie; N Tajuddin; R M Mitchell; E J Neafsey; M A Collins
Journal:  Neurotox Res       Date:  2018-03-12       Impact factor: 3.911

Review 2.  Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.

Authors:  Veeral H Ajmera; Norah A Terrault; Stephen A Harrison
Journal:  Hepatology       Date:  2017-04-28       Impact factor: 17.425

3.  Insulin Production and Resistance in Different Models of Diet-Induced Obesity and Metabolic Syndrome.

Authors:  Salamah M Alwahsh; Benjamin J Dwyer; Shareen Forbes; David H van Thiel; Philip J Starkey Lewis; Giuliano Ramadori
Journal:  Int J Mol Sci       Date:  2017-01-28       Impact factor: 5.923

Review 4.  Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Inbeom Kwon; Dae Won Jun; Jin-Hwa Moon
Journal:  Gut Liver       Date:  2019-05-15       Impact factor: 4.519

5.  Moderate consumption of fermented alcoholic beverages diminishes diet-induced non-alcoholic fatty liver disease through mechanisms involving hepatic adiponectin signaling in mice.

Authors:  Finn Jung; Tino Lippmann; Annette Brandt; Cheng Jun Jin; Anna Janina Engstler; Anja Baumann
Journal:  Eur J Nutr       Date:  2019-03-16       Impact factor: 5.614

Review 6.  Experimental models of metabolic and alcoholic fatty liver disease.

Authors:  Delfin Gerard Buyco; Jasmin Martin; Sookyoung Jeon; Royce Hooks; Chelsea Lin; Rotonya Carr
Journal:  World J Gastroenterol       Date:  2021-01-07       Impact factor: 5.742

7.  Effects of Resveratrol Against Induced Metabolic Syndrome in Rats: Role of Oxidative Stress, Inflammation, and Insulin Resistance.

Authors:  Doha Reda; Gehad E Elshopakey; Hebatallah A Mahgoub; Engy F Risha; Anmar A Khan; Bodour S Rajab; Mohamed E El-Boshy; Fatma M Abdelhamid
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-11       Impact factor: 2.650

8.  Chronic Alcohol Consumption is Inversely Associated with Insulin Resistance and Fatty Liver in Japanese Males.

Authors:  Takemi Akahane; Tadashi Namisaki; Kosuke Kaji; Kei Moriya; Hideto Kawaratani; Hiroaki Takaya; Yasuhiko Sawada; Naotaka Shimozato; Yukihisa Fujinaga; Masanori Furukawa; Koh Kitagawa; Takahiro Ozutsumi; Yuuki Tsuji; Daisuke Kaya; Hiroyuki Ogawa; Hirotetsu Takagi; Koji Ishida; Hitoshi Yoshiji
Journal:  Nutrients       Date:  2020-04-09       Impact factor: 5.717

9.  The gut microbiome as mediator between diet and its impact on immune function.

Authors:  Huiqing Shi; Rob Ter Horst; Suzanne Nielen; Mirjam Bloemendaal; Martin Jaeger; Irma Joosten; Hans Koenen; Leo A B Joosten; Lizanne J S Schweren; Alejandro Arias Vasquez; Mihai G Netea; Jan Buitelaar
Journal:  Sci Rep       Date:  2022-03-25       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.